๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sample size re-estimation in clinical trials

โœ Scribed by Michael A. Proschan

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
158 KB
Volume
51
Category
Article
ISSN
0323-3847

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Design for sample size re-estimation wit
Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes
โœ Weichung Joseph Shih; Peng-Liang Zhao ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB ๐Ÿ‘ 2 views

Estimation of sample size in clinical trials requires knowledge of parameters that involve the treatment effect and variability, which are usually uncertain to medical researchers. The recent release within the European Union of a Note for Guidance from the Commission for Proprietary Medical Product

Sample size and power issues in estimati
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data
โœ Andrew R. Willan; Bernie J. O'Brien ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 2 views

It is becoming increasingly more common for a randomized controlled trial of a new therapy to include a prospective economic evaluation. The advantage of such trial-based cost-effectiveness is that conventional principles of statistical inference can be used to quantify uncertainty in the estimate o